Leaflet EXALIEF 600mg tablets


Indicated for: epilepsy

Route of administration: oral

Substance: eslicarbazepine (antiepileptic)

ATC: N03AF04 (Nervous system | Antiepileptics | Carboxamide derivatives)

Eslicarbazepinum is a medication used for the treatment of focal epileptic seizures, with or without secondary generalization, in adults and children aged 6 years and older. It is an antiepileptic drug that works by blocking voltage-gated sodium channels, reducing neuronal excitability.

The medication is taken orally, usually once daily, as directed by a doctor. The dosage is adjusted based on the patient's response and tolerance to treatment.

Common side effects include dizziness, drowsiness, nausea, headache, and fatigue. In rare cases, more severe adverse effects such as severe skin rashes or liver function impairment may occur.

Eslicarbazepinum is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions.

General data about EXALIEF 600mg

  • Substance: eslicarbazepine
  • Date of last drug list: 01-07-2013
  • Commercial code: W54457001
  • Concentration: 600mg
  • Pharmaceutical form: tablets
  • Quantity: 30
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Concentrations available for eslicarbazepine

  • 400mg
  • 600mg
  • 800mg